FDA Approved: BUPRENORPHINE AND NALOXONE — Original Application (INGENUS PHARMACEUTICALS, LLC)

View source ↗

Summary

FDA approved a generic buprenorphine and naloxone combination (Ingenus Pharmaceuticals) under ANDA212756 for the treatment of opioid use disorder.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Opioid Use Disorder

Drugs mentioned

• Buprenorphine and naloxone (BUPRENORPHINE AND NALOXONE)

Snippet

ORIG AP for BUPRENORPHINE AND NALOXONE (BUPRENORPHINE AND NALOXONE)